Two cohort of patients will be followed to examine the course of illness in Alzheimer's disease. We will contrast two hypotheses of illness progression: 1) initiation in the medial temporal lobe and spread through the corticocortical projections to the lateral temporal, frontal and parietal lobes and 2) multilocal or global initiation as the variable regional expression of a common underlying diffuse pathological process. In the first cohort (data collected at the University of California, Irvine), 39 patients with mild to moderate Alzheimer's disease received PET Scans and co-registered MRI Scans, neurological examinations, and a battery of neuropsychological assessments in 1989-1990. These patients and their matched elderly normal controls are currently receiving 2-year clinical followup, and will be contacted regularly during the course of the project. These patients have already received a repeat scan. For the second cohort (data to be collected at Mt. Sinai), the ADRC Clinical Research Support Core will recruit and diagnose patients from the Mt.Sinai geriatric programs. We will PET and MRI scan and assess 16 patients each year, eight with memory deficits not meeting NINCDS criteria for AD (Mini-mental more 20 and CDR=0.5; termed """"""""questionable AD"""""""") and eight meeting criteria for mild Alzheimer's disease (CDR 0.5 or 1.0) and meet NINCDS ADRDA criteria for AD. Patients will receive a second set of scans after 24 and 48 months; during this funding period not all patients will receive 48 month followup. The ADRC Core will provide followup at six month intervals. Approximately 68% of patients entering the ADRC will come to autopsy. While relatively few will be available in the first five year period, we will have the PET and MRI database for analysis of regional neurofibrillary tangle and plaque counts for the second grant period. From this sample rescanned at regular intervals we will learn if medial temporal lobe change is systematically followed by lateral cortical deficits. The specificity of neuroanatomical sites identified in cohort 1 will be replicated at higher resolution in cohort 2. A complete life span normal control group (ages 20-80) performing the same task during FDG uptake will be available for comparison. Scans will be carried out on our new high-resolution, head dedicated GE 2048 PET Scanner with FDG as the tracer and a verbal memory task. Matching MRI Scans will be obtained for co-registration and assessment of gray/white matter change.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005138-13
Application #
5204478
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1996
Total Cost
Indirect Cost
Zhu, Carolyn W; Grossman, Hillel; Neugroschl, Judith et al. (2018) A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: A pilot study. Alzheimers Dement (N Y) 4:609-616
Boban, Mirta; Babi? Leko, Mirjana; Miški?, Terezija et al. (2018) Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species. J Neurosci Methods :
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Silverman, Jeremy M; Schmeidler, James (2018) Outcome age-based prediction of successful cognitive aging by total cholesterol. Alzheimers Dement 14:952-960
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Warren, Noel A; Voloudakis, Georgios; Yoon, Yonejung et al. (2018) The product of the ?-secretase processing of ephrinB2 regulates VE-cadherin complexes and angiogenesis. Cell Mol Life Sci 75:2813-2826

Showing the most recent 10 out of 555 publications